MedTech Navigator Program
Connecting Australian MedTech to Global Opportunities
Build the capability, connections and market insight needed to expand beyond Australia.
Breaking into international markets takes more than a strong product. You need to understand where your company fits, what global buyers are looking for, and what it will take to meet the expectations of regulators, partners and international supply chains.
The MTAA MedTech Navigator Program gives Australian MedTech companies the practical knowledge, industry connections and export readiness support to start building a clear pathway into global markets.
Built for Australian MedTech companies ready to grow
MedTech Navigator is a national program for emerging and growth-stage Australian MedTech companies looking towards international expansion, particularly across Europe and Asia.
It is designed for companies progressing from early-stage development toward commercialisation. While your core technology may still be evolving, you should have an emerging proof of concept and be beginning to explore global markets, regulatory considerations, and commercial pathways.
Navigator may be right for your company if you are:
- Considering international markets for the first time
- Preparing to expand beyond Australia
- Exploring global partnerships or distribution opportunities
- Building the commercial and regulatory capability needed for export
- Looking to understand where your innovation fits within global MedTech supply chains
One Program – 2 Streams
Stream 1: Reverse Pitches
Medtech Navigator turns the traditional pitch format around.
Rather than asking Australian companies to pitch without knowing what international organisations need, senior executives from global MedTech companies will present their procurement priorities, supply chain needs and partnership opportunities directly to Australian innovators.
These sessions will give you a clearer view of:
- The problems global MedTech companies are trying to solve
- Current procurement and supply chain priorities
- Where Australian capabilities may fill an identified need
- What international organisations expect from prospective partners
- The reverse pitch series is open to wider Australian MedTech industry.
Stream 2: Market Access Readiness Workshops
A selected cohort will have access to five (5) structured Market Access Readiness Modules. Each module combines expert-led content with practical worksheets and outputs that companies can apply directly to their own international growth planning.
Places in the Market Access Readiness Workshops are limited, allowing participating companies to receive more focused, hands-on export readiness support.
By the end of the program, you will have developed a clearer understanding of your international opportunity and a practical plan for what comes next.
Workshop 1: Global MedTech landscape and positioning
Understand how international MedTech markets and multinational supply chains operate, what buyers expect, and where your company may fit within global value chains.
You will develop: A global positioning hypothesis.
Workshop 2: Regulatory and market access reality
Explore how regulatory pathways shape commercial feasibility across key markets, including Europe, Japan and the United States. Understand the relationship between regulation, reimbursement and realistic time to market.
You will develop: A regulatory readiness map
Workshop 3: Global value proposition and commercial storytelling
Turn technical innovation into clear, buyer-ready commercial messaging. Learn how to communicate your value through cost, workflow, scalability, evidence, reimbursement and supply chain fit.
You will develop: A commercial pitch framework.
Workshop 4. Partnerships and supply chain integration
Prepare to engage confidently with distributors, global companies and strategic partners. Explore partner selection, distribution models, pilot structures, negotiation fundamentals and integration readiness.
You will develop: A partner engagement strategy map.
Workshop 5. Export execution and market entry planning
Bring your learning together into an actionable export roadmap, with clear priority markets, resource requirements, risks and next steps.
You will develop: A 6 to 12-month export execution plan
Why MedTech Navigator Matters
A promising technology alone does not create an international opportunity. Companies also need to understand buyer expectations, regulatory requirements, commercial positioning, partnership models and their role within a much larger global value chain.
MedTech Navigator brings those pieces together. It is designed to help participating companies:
- Hear directly from global MedTech decision-makers
- Understand what international buyers and partners need
- Strengthen commercial, regulatory and pitching capability
- Build a clearer strategy for partnership and distribution
- Turn export ambition into an actionable market entry plan
This is not about rushing into an overseas market. It is about making better decisions now, so your company is better prepared when the right opportunity arrives.
Supported by Industry and Government
MedTech Navigator is delivered in collaboration with the Australian Trade and Investment Commission, Austrade.
The Trade Diversification Network (TDN) has been set up to deliver the Accessing New Markets Initiative (ANMI). The network consists of 40 national peak industry bodies – representing Australian exporters.
Through the TDN, the Australian Government and industry are uniting to support exporters to diversify and grow into new markets, leveraging the combined capabilities and expertise of government and industry. Austrade is collaborating with national peak industry bodies to ensure ANMI support is fit-for-purpose and aligned with the needs of their members.
The TDN's adaptive delivery model enables the program to readily respond to market conditions and shifting trade flow. This ensures ANMI support for Australian exporters is flexible and targeted. By strengthening relationships with industry and government, the program will deliver enduring outcomes, by identifying strategies that best support exporters in the long term.
By combining MTAA’s industry connections with Austrade’s international trade expertise and networks, MedTech Navigator helps Australian companies better understand and prepare for opportunities in global markets.
Learn more about Austrade’s Trade Diversification Network
Start building the capability to reach it
Applications are now open for the first MedTech Navigator cohort.
With a limited number of participating companies and applications closing on 18 September 2026, early-stage and growth-stage MedTech businesses considering international expansion are encouraged to apply now.
Applications close 18 September 2026.
